GuidanceMHRA
Labelling and packaging of medicinal products for human use following agreement of the Windsor Framework
Information on the implementation of labelling and packaging requirements for medicinal products for human use under the Windsor Framework.
First published: Jul 27, 2023Last updated: Mar 11, 2025Changes: 7
Latest change: Updated to remove: “1. Subject to the UK providing written guarantees to the European Commission as provided for in Article 8 of EU Regulation 2023/1182 and following the entry into force and application procedure provided for in Article 14” from document Labelling and packaging of medicinal products for human use following agreement of the Windsor Framework
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.